Bilimsel çalışmalar

Prof. Dr. Çağlayan Geredeli

121 yayın. Her yayının yanında bilginin kaynağı yazar.

Profile dön
  1. Prognostic Significance of Mean Platelet Volume on Local Advanced Non-Small Cell Lung Cancer Managed with Chemoradiotherapy

    Scientific Reports, 2019

    DOI 10.1038/s41598-019-40589-4 PMID 30850724 16 atıf (Europe PMC) Açık erişimli tam metinKaynak: OpenAlex

  2. The effect of different treatment modalities on survival in elderly patients with locally advanced non-small cell lung cancer

    Pulmonology, 2019

    DOI 10.1016/j.pulmoe.2019.11.007 PMID 31839507 14 atıf (Europe PMC) Açık erişimli tam metinKaynak: OpenAlex

  3. Clinicopathologic and Prognostic Differences between Three Different Age Groups (Child/Adolescent, Young Adults, and Adults) of Colorectal Cancer Patients: A Multicentre Study

    Oncology Research and Treatment, 2019

    DOI 10.1159/000502120 PMID 31437835 10 atıf (Europe PMC) Açık erişimli tam metinKaynak: OpenAlex

  4. The effects of diabetes and fasting plasma glucose on treatment of breast cancer with neoadjuvant chemotherapy

    Current Problems in Cancer, 2019

    DOI 10.1016/j.currproblcancer.2019.05.007 PMID 31200961 12 atıf (Europe PMC) Kaynak: OpenAlex

  5. The effect of body mass index on location of recurrence and survival in early-stage colorectal cancer

    Journal of Cancer Research and Therapeutics, 2019

    DOI 10.4103/jcrt.jcrt_326_18 PMID 33380674 12 atıf (Europe PMC) Açık erişimli tam metinKaynak: OpenAlex

  6. Effect of Pretreatment Platelet Parameters on Survival in Limited Disease Small Cell Lung Cancer

    Asian Pacific Journal of Cancer Prevention, 2019

    DOI 10.31557/apjcp.2019.20.6.1879 PMID 31244313 9 atıf (Europe PMC) Açık erişimli tam metinKaynak: OpenAlex

  7. Factors affecting survival and treatment efficacy in breast cancer patients with bone marrow metastasis

    The Breast Journal, 2019

    DOI 10.1111/tbj.13647 PMID 31562662 10 atıf (Europe PMC) Açık erişimli tam metinKaynak: OpenAlex

  8. Prognostic impact of blood transfusion in patients with metastatic non-small cell lung cancer receiving chemotherapy

    Lung Cancer, 2019

    DOI 10.1016/j.lungcan.2019.05.007 PMID 31200825 4 atıf (Europe PMC) Kaynak: OpenAlex

  9. Factors Affecting Disease-Free Survival in Operated Nonmetastatic Gastrointestinal Stromal Tumors

    Journal of Surgical Research, 2019

    DOI 10.1016/j.jss.2019.03.059 PMID 31026795 4 atıf (Europe PMC) Kaynak: OpenAlex

  10. Factors affecting survival in patients with isolated liver-metastatic colorectal cancer treated with local ablative or surgical treatments for liver metastasis.

    PubMed, 2019

    PMID 31786840 5 atıf (Europe PMC) Kaynak: OpenAlex

  11. The evaluation of efficacy and tolerability of gemcitabine vs. capecitabine therapy in the second-line setting for metastatic pancreatic cancer patients with poor performance status

    Journal of Oncological Sciences, 2019

    DOI 10.1016/j.jons.2019.08.003 1 atıf (OpenAlex) Açık erişimli tam metinKaynak: OpenAlex

  12. Efficacy and tolerability of adjuvant therapy in ≥70-year-old patients with T3N0M0 colorectal cancer: An observational study

    Journal of Oncology Pharmacy Practice, 2019

    DOI 10.1177/1078155219865008 PMID 31366267 3 atıf (Europe PMC) Kaynak: OpenAlex

  13. The effects of fulvestrant treatment on hormone receptor-positive metastatic breast cancer

    The European Research Journal, 2019

    DOI 10.18621/eurj.470881 1 atıf (OpenAlex) Açık erişimli tam metinKaynak: OpenAlex

  14. Non-urothelial Bladder Cancers: Single Center Experience

    European Archives of Medical Research, 2019

    DOI 10.4274/eamr.galenos.2019.21931 Açık erişimli tam metinKaynak: OpenAlex

  15. Adrenocortical Carcinoma: Single Center Experience

    European Archives of Medical Research, 2019

    DOI 10.4274/eamr.25744 Açık erişimli tam metinKaynak: OpenAlex

  16. Is eribulin treatment prognostic factor in patients with metastatic breast cancer treated with this drug? Retrospective analysis of a multicentre study.

    PubMed, 2019

    PMID 31786850 1 atıf (Europe PMC) Kaynak: OpenAlex

  17. Factors Affecting Survival in Neuroendocrine Tumors: A 15-Year Single Center Experience

    Asian Pacific Journal of Cancer Prevention, 2018

    DOI 10.31557/apjcp.2018.19.12.3597 PMID 30583688 9 atıf (Europe PMC) Açık erişimli tam metinKaynak: OpenAlex

  18. Prognostic significance of primary tumor localization in stage II and III colon cancer

    World Journal of Gastrointestinal Oncology, 2018

    DOI 10.4251/wjgo.v10.i11.410 PMID 30487952 6 atıf (Europe PMC) Açık erişimli tam metinKaynak: OpenAlex

  19. Effectiveness and tolerability of FOLFIRINOX regime in metastatic pancreas cancer disease

    The Medical Journal of Okmeydani Training and Research Hospital, 2018

    DOI 10.5222/otd.2018.71224 1 atıf (OpenAlex) Açık erişimli tam metinKaynak: OpenAlex

  20. The prognostic significance of the 18F-fluorodeoxyglucose positron emission tomography/computed tomography in early-stage nonsmall cell lung cancer

    Journal of Cancer Research and Therapeutics, 2018

    DOI 10.4103/jcrt.jcrt_911_17 PMID 32930124 2 atıf (Europe PMC) Açık erişimli tam metinKaynak: OpenAlex

  21. Fulvestrant efficacy in artificial menopausal hormone receptor positive and HER 2 negative metastatic breast cancer patients under 50 years old.

    Journal of Clinical Oncology, 2018

    DOI 10.1200/jco.2018.36.15_suppl.e13000 Kaynak: OpenAlex

  22. Opere erken evre kolon kanserinde vücut kitle indeksinin nüks lokalizasyonu, hastalıksız sağkalım ve genel sağkalım etkisi

    Van Yüzüncü Yıl University Academic Data Management System, 2018

    Kaynak: OpenAlex

  23. Erken evre(1-3) kolon kanseri hastalarında tümör lokalizasyonunun hastalıksı sağkalım ve genel sağkalıma etkisi:tek merkez deneyimi

    Van Yüzüncü Yıl University Academic Data Management System, 2018

    Kaynak: OpenAlex

  24. Hormon pozitif metastatik meme kanseri tedavisinde Fulvestrant etkinlik ve tolerabilitesi

    Van Yüzüncü Yıl University Academic Data Management System, 2018

    Kaynak: OpenAlex

  25. The Relationship Between Pathological Complete Response and Ki 67 İndex in Patients with Locally Advanced Breast Cancer Receiving Neoadjuvant Chemotherapy: Retrospective Single Center Experience

    Van Yüzüncü Yıl University Academic Data Management System, 2018

    Kaynak: OpenAlex

  26. Pleomorfik Sarkom tanılı hastada ifosfamid toksisitesi

    Van Yüzüncü Yıl University Academic Data Management System, 2018

    Kaynak: OpenAlex

  27. Opere iyi diferansiye Gastroenteropankreatik nöroendokrin tümörlerde Lenf nodu tutulumunun ve primer tümör lokalizasyonunun Klinik önemi

    Van Yüzüncü Yıl University Academic Data Management System, 2018

    Kaynak: OpenAlex

  28. Metastatik mide kanserinde tanı anındaki PET-CT SUV-Max değerinin prognostik önemi

    Van Yüzüncü Yıl University Academic Data Management System, 2018

    Kaynak: OpenAlex

  29. Nüks Apendiks Adenokarsinoid Tümörü:Olgu Sunumu ve Literatür Güncellemesi

    Van Yüzüncü Yıl University Academic Data Management System, 2018

    Kaynak: OpenAlex

  30. P3.01-33 EGFR Mutation in Patients with NSCLC and Its Relationship Between Survival and Clinicopathological Features: An Update Analysis

    Journal of Thoracic Oncology, 2018

    DOI 10.1016/j.jtho.2018.08.1593 Açık erişimli tam metinKaynak: OpenAlex

  31. Prognostic factors of patients who received chemotherapy after cranial irradiation for non-small cell lung cancer with brain metastases: A retrospective analysis of multicenter study (Anatolian Society of Medical Oncology)

    Journal of Cancer Research and Therapeutics, 2018

    DOI 10.4103/0973-1482.176417 PMID 29893321 5 atıf (Europe PMC) Açık erişimli tam metinKaynak: OpenAlex

  32. FOLFIRI plus panitumumab in the treatment of wild-type KRAS and wild-type NRAS metastatic colorectal cancer

    World Journal of Surgical Oncology, 2018

    DOI 10.1186/s12957-018-1359-9 PMID 29587749 4 atıf (Europe PMC) Açık erişimli tam metinKaynak: ORCID

  33. Folfiri plus panitumumab as the first-line treatment in patients with RAS wild-type metastatic colorectal cencer. A single center experience.

    The Medical Journal of Okmeydani Training and Research Hospital, 2018

    DOI 10.5222/otd.2018.70431 Açık erişimli tam metinKaynak: OpenAlex

  34. Efficacy and tolerability of eribulin mesylate in the treatment of anthracycline and taksan resistance to metastatic breast cancer. Single central experience

    Ortadoğu Tıp Dergisi, 2018

    DOI 10.21601/ortadogutipdergisi.409706 Açık erişimli tam metinKaynak: OpenAlex

  35. Metastatik Pankreaas Kanserli Türk Hastalarda FOLFİRİNOX Rejiminin Etkinlik ve Tolerabilitesi

    Van Yüzüncü Yıl University Academic Data Management System, 2017

    Kaynak: OpenAlex

  36. METASTATİK PANKREAS KANSERLİ TÜRK HASTALARDA FOLFİRİNOX REJİMİNİN ETKİNLİK VE TOLERABİLİTESİ.

    Çanakkale Onsekiz Mart University AVESIS, 2017

    Kaynak: OpenAlex

  37. The impact of ramazan i’tikaf on immune system

    Malaysian Journal of Public Health Medicine, 2017

    DOI 10.37268/mjphm/vol.17/no.3/art.221 1 atıf (OpenAlex) Açık erişimli tam metinKaynak: ORCID

  38. EGFR-targeted treatments in patients with metastatic colorectal cancer: Experience of panitumumab.

    Journal of Clinical Oncology, 2017

    DOI 10.1200/jco.2017.35.15_suppl.e15028 Açık erişimli tam metinKaynak: OpenAlex

  39. What are the differences between young (≤25 years) and adults (>25 years) colorectal cancer (CRC)? An Anatolian Society of Medical Oncology Study.

    Journal of Clinical Oncology, 2015

    DOI 10.1200/jco.2015.33.15_suppl.e14657 Açık erişimli tam metinKaynak: OpenAlex

  40. Gastric metastasis of triple negative invasive lobular carcinoma

    Rare Tumors, 2015

    DOI 10.4081/rt.2015.5764 PMID 26266010 13 atıf (Europe PMC) Açık erişimli tam metinKaynak: ORCID

  41. Prognostic factors for gemcitabinerefractory patients with advanced pancreatic cancer: A retrospective analysis of a multicentre study (Anatolian society of medical oncology)

    Wspolczesna Onkologia, 2015

    DOI 10.5114/wo.2014.43933 PMID 26034390 1 atıf (Europe PMC) Açık erişimli tam metinKaynak: ORCID

  42. Prognostic value of ERCC1, ERCC2, XRCC1, and TP53 single nucleotide polymorphisms in patients with early-stage non-small cell lung cancer

    Tumor Biology, 2015

    DOI 10.1007/s13277-015-3066-2 PMID 25596702 8 atıf (Europe PMC) Kaynak: ORCID

  43. Biatrial Cardiac Metastases in a Patient with Uterine Cervix Malignant Melanoma

    Case Reports in Cardiology, 2015

    DOI 10.1155/2015/958756 PMID 26060585 6 atıf (OpenAlex) Açık erişimli tam metinKaynak: OpenAlex

  44. Comparison of in-Hospital Cardiopulmonary Resuscitation Results Before and After the Introduction Code Blue

    Turkiye Klinikleri Journal of Anesthesiology Reanimation, 2015

    DOI 10.5336/anesthe.2014-42431 2 atıf (OpenAlex) Açık erişimli tam metinKaynak: OpenAlex

  45. Metastatik meme kanserinde beyin metastazlarının erken veya geç saptanmasının ve diğer prognostik faktörlerin sağ kalıma etkisi var mı ?

    Çanakkale Onsekiz Mart University AVESIS, 2015

    Kaynak: OpenAlex

  46. Pathologic and Clinical Characteristics of Elderly Patients With Breast Cancer: A Retrospective Analysis of a Multicenter Study (Anatolian Society of Medical Oncology)

    International Surgery, 2014

    DOI 10.9738/intsurg-d-13-00010 PMID 24444261 6 atıf (Europe PMC) Açık erişimli tam metinKaynak: OpenAlex

  47. Abiraterone acetate (AA) in patients with metastatic castration-resistant prostate cancer (MCRPC) after docetaxel chemotherapy: Multicentric experience of Anatolian Society of Medical Oncology.

    Journal of Clinical Oncology, 2014

    DOI 10.1200/jco.2014.32.15_suppl.e16094 2 atıf (OpenAlex) Kaynak: OpenAlex

  48. P0146 The prognostic role of XRCC1, ERCC1, ERCC2, and TP53 single nucleotide polymorphisms in resected non-small-cell lung cancer

    European Journal of Cancer, 2014

    DOI 10.1016/j.ejca.2014.03.190 Kaynak: OpenAlex

  49. Relation of metastatic stage at the diagnosis of non-small cell lung cancer (NSCLC) to XRCC1 and TP53 single nucleotide polymorphisms (SNPs).

    Journal of Clinical Oncology, 2014

    DOI 10.1200/jco.2014.32.15_suppl.e19109 Kaynak: OpenAlex

  50. Childhood, Adolescents, and Young Adults (≤25 y) Colorectal Cancer

    Journal of Pediatric Hematology/Oncology, 2013

    DOI 10.1097/mph.0b013e31827e7f20 PMID 23337551 22 atıf (Europe PMC) Açık erişimli tam metinKaynak: OpenAlex